Not all shilajit is created equal. Based on the clinical trials referenced earlier, the effective dosage range for purified shilajit is typically 250 mg to 500 mg per day. Because shilajit is a potent natural substance sourced from the earth, quality control is the single most critical factor in its use. Since high cortisol is a known testosterone killer, this stress-reducing property indirectly supports your hormonal goals while directly improving your mood and mental resilience. It helps regulate the hypothalamic-pituitary-adrenal (HPA) axis, potentially lowering cortisol levels. The dibenzo-alpha-pyrones in shilajit prevent the breakdown of acetylcholine, a neurotransmitter critical for memory and focus. This results in sustained stamina and physical endurance, allowing you to push harder in the gym and maintain high energy levels throughout the workday. Unlike caffeine, which stimulates the central nervous system and can lead to jitters or a crash, shilajit supports the actual generation of energy. Fatigue is often the first symptom of declining male health. Α-Lipoic acid must interact with these enzymesin order for aerobic metabolism to proceed . The most importantdietary sources of α-lipoic acid are spinach and broccoli . Exogenous (dietary)α-lipoic acid is absorbed into the human circulation and contributesto the human α-lipoic acid pool 336,337. On the other hand, testosterone-dependent immunossuppression could also be the consequence of an ‘indirect pathway’ (Owen-Ashley et al. 2004) mediated by the pro-oxidant properties of this androgen, as firstly proposed by von Schantz et al. (1999). Androgens increase angiotensin II production, which regulates vasoconstriction by producing peroxides from NADH- and NADPH-oxidase (Reckelhoff 2001). Alternatively or additionally, the effect could be mediated by the role of androgens in the regulation of blood pressure. Theresults of a metα-analysis of the combined results of 54 previouslypublishedcross-sectional observational studies and 7 double-blindrandomized placebo-controlled clinical trials indicated that the riskfor developing any form of cardiovascular disease was inverselycorrelated with the serum total testosterone concentration . Cardiovascular and cerebrovascular health are compromised bylow normal serum testosterone concentrations 81,82,86,87,89-97.For example, in the 5-year prospective observational Health in Menstudy of men aged 70 years or older in Australia, the combined riskfor first stroke or first transient ischemic attack was doubled in menwith initial serum total testosterone concentrations less than 11.7nmol/L . Circulating testosterone is converted into 17β-estradiol by thearomatase enzyme complex embedded within the membranes ofthe endoplasmic reticulum of testicular Leydig and Sertoli cells,spermatocytes, prostate epithelial cells, bone, adipose tissue, andother organs in men (Figure 4) 17-21. Reliance on the mitochondrial electrontransfer system for the energy to drive testosterone synthesis exposes Leydigcell mitochondria to oxidative stress. This study demonstrated that low-dose testosterone serves as a protective agent in cultured Leydig's cells. In the in vitro study, the testosterone supplementation could modulate intracellular testosterone production that was not through hypothalamus–pituitary gland–testis axis, and may be modulated via ROS signaling pathway or non-genomic signaling pathway. In this study, increased lipid peroxidation was also found in ≥200-nmol l−1 testosterone-treated cells. In this study, we propose that testosterone therapy prevented cells from oxidative stress-induced damage and cell death; moreover, we explored the beneficial effects (cell viability and steroidogenesis) and potential risks (ROS generation, lipid peroxidation and hypoxic stress) of testosterone supplementation using the TM3 Leydig cell line as an in vitro cell model. Our study used low-dose (100 nmol l−1) testosterone treatment in vitro in order to mimic local effects of testosterone on Leydig cells. In this study, we tested the hypothesis that testosterone generates measurable costs in terms of oxidative stress in a bird species, the zebra finch, whose males harbour a testosterone-dependent ornament. Since testosterone usually enhances the metabolic rate (e.g. Feuerbacher & Prinzinger 1981; Fryburg et al. 1997; Buchanan et al. 2001), one could expect that high testosterone levels, necessary to the production of sexual ornaments, might alter the balance between ROS production and antioxidant defences, resulting in an enhanced risk of oxidative stress. Yes, research confirms that purified shilajit effectively supports testosterone production, improves sperm quality, and increases cellular energy (ATP) levels in men. Conversely, antioxidant defenses can be augmented by dietarysupplementation with specific antioxidant and mitochondrialprotective nutrients that reduce cell-wide oxidative damage,support redox balance within Leydig cells, release Leydig cells fromoxidative inhibition of testosterone synthesis, and increase the rateof testosterone secretion. This study was financially supported by the Shin Kong Wu Ho-Su Memorial Hospital (SKH-TMU-93-43). TIH and SHK participated in the design and concept formation of this study. Although further investigations of the mechanism governing the differential effects of testosterone treatment are needed, our in vitro results provide the first clues for further animal and clinical tests and shed light on testosterone replacement therapy. Clinically, the proper application of testosterone replacement therapy is of great concern. As for ROS generation, the epitestosterone showed similar effect to testosterone.